Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Victor Shifrin"'
Autor:
Victor Shifrin, Nader Sheibani, Andrew Suscha, Christine M. Sorenson, Yong Seok Song, Soesiawati R. Darjatmoko, Shoujian Wang, Ismail Zaitoun, Irawati Kandela, Jack Henkin, Ignacio Melgar-Asensio, Daniel M. Albert
Publikováno v:
Exp Eye Res
Retinopathy of prematurity (ROP) is a growing cause of lifelong blindness and visual defects as improved neonatal care worldwide increases survival in very-low-birthweight preterm newborns. Advancing ROP is managed by laser surgery or a single intrav
Autor:
Vladimir L. Gabai, Victor Shifrin
Publikováno v:
International Reviews of Immunology
Cancer immunotherapy is a thriving field, but its clinical achievements are modest so far. One of its major hurdles seems to be finding a feasible cancer antigen as a target for immune response. After many years of research, three major criteria for
Autor:
Elena Vinokour, Victor Shifrin, Ignacio Melgar-Asensio, Jim Petrik, Marisol Villanueva, Reshma Bhowmick, Michael P. Plebanek, Raghu Kallurie, Olga V. Volpert, Jack Henkin
Publikováno v:
Cancer Research. 78:3133-3133
Purpose: Ovarian cancer is the deadliest gynecologic malignancy with limited treatment options and novel therapies urgently needed. Immunosuppressive microenvironment is critical for tumor progression and immune checkpoint inhibitors, which enable T-
Autor:
Arin B. Aurora, Olga V. Volpert, Charles Polsky, Richard P. Beckmann, Ahmed Deabes, Frank T. Schulze-Hoepfner, Victor Shifrin, Yelena Mirochnik
Publikováno v:
Clinical Cancer Research. 15:1655-1663
Purpose: Pigment epithelial-derived factor (PEDF) is a potent angiogenesis inhibitor with multiple other functions, some of which enhance tumor growth. Our previous studies mapped PEDF antiangiogenic and prosurvival activities to distinct epitopes. T
Autor:
Melania Capitani, Maria Giovanna Sabbieti, Antonio Concetti, Michael Y. Sherman, Vladimir L. Gabai, Franco M. Venanzi, Giuseppe Catone, Luigi Marchetti, Alexander M. Shneider, Cecilia Vullo, Dimitrios Agas, Victor Shifrin
Publikováno v:
Scopus-Elsevier
Oncotarget
Oncotarget
// Maria Giovanna Sabbieti 1, * , Dimitrios Agas 1, * , Melania Capitani 1 , Luigi Marchetti 1 , Antonio Concetti 1 , Cecilia Vullo 1 , Giuseppe Catone 1 , Vladimir Gabai 2 , Victor Shifrin 2 , Michael Y Sherman 3 , Alexander Shneider 2 , Franco M Ve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90df62ff72d34253c34e9078d87b5d91
http://hdl.handle.net/11581/365399
http://hdl.handle.net/11581/365399
Autor:
Andrey Chursov, Antonio Concetti, Giuseppe Catone, Michael Y. Sherman, Vita Shcherbinina, Victor Shifrin, Francesca Mariotti, Franco M. Venanzi, Elena Bagashova, Oksana Rud, A. A. Latanova, Vladimir L. Gabai, Cecilia Vullo, Alexander M. Shneider
Publikováno v:
Scopus-Elsevier
Oncotarget
Oncotarget
Our previous data demonstrated profound anti-tumor and anti-metastatic effects of p62 (sqstm1) DNA vaccine in rodents with various types of transplantable tumors. Testing anti-cancer medicine in dogs as an intermediary step of translational research
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f86dd4b9a9d7a57d4127c1041433f127
http://hdl.handle.net/11581/347381
http://hdl.handle.net/11581/347381
Publikováno v:
Journal of Biological Chemistry. 273:6373-6379
Inhibition of the major cytosolic protease, proteasome, has been reported to induce programmed cell death in several cell lines, while with other lines, similar inhibition blocked apoptosis triggered by a variety of harmful treatments. To elucidate t
Autor:
Michael Y. Sherman, Vladimir L. Gabai, Dick D. Mosser, Victor Shifrin, Anatoli B. Meriin, Sophia Rits, Antoine W. Caron
Publikováno v:
Journal of Biological Chemistry. 272:18033-18037
Harmful conditions including heat shock, oxidative stress, UV, and so forth cause programmed cell death, whose triggering requires activation of the Jun N-terminal kinase, JNK. High levels of Hsp72, a heat-inducible member of Hsp70 family, protect ce
Autor:
Victor Shifrin, Sharon McGonigle
Publikováno v:
Current Protocols in Pharmacology
The growth of new blood vessels, or angiogenesis, is a naturally occurring process in both health and disease states. An area of active research, regulation of angiogenesis, is being studied as an approach for the treatment of cancer and a range of o
Autor:
Victor Shifrin, Grudinin Mp, Natalya Bezdenezhnykh, Franco M. Venanzi, E. A. Romanovskaya-Romanko, Raisa Yakubovsky, Andrey Chursov, Antonio Concetti, Andrey Komissarov, Yuri Kudryavets, Nadiia Semesyuk, Oleg I. Kiselev, Oleksandra Lykhova, Marina Filimonova, Victoria Makarchuk, Anatoly F. Tsyb, Vita Shcherbinina, Maria Shartukova, Michael Y. Sherman, Alexander M. Shneider, Vladimir L. Gabai
Publikováno v:
Scopus-Elsevier
Oncotarget
ResearcherID
Oncotarget
ResearcherID
// Franco Venanzi 1,* , Victor Shifrin 2,* , Michael Y. Sherman 3 , Vladimir Gabai 2 , Oleg Kiselev 4 , Andrey Komissarov 4 , Mikhail Grudinin 4 , Maria Shartukova 4 , Ekaterina A. Romanovskaya-Romanko 4 , Yuri Kudryavets 5 , Natalya Bezdenezhnykh 5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccb89d9606ea3cea38d3ba0e14c2adf2
http://www.scopus.com/inward/record.url?eid=2-s2.0-84886732236&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-84886732236&partnerID=MN8TOARS